As the pan-European STOXX Europe 600 Index remains relatively stable amidst ongoing U.S. and European trade discussions, investors are keenly observing market dynamics for opportunities. In this environment, identifying undervalued stocks can be particularly appealing, as they may offer potential value relative to their current trading prices.

Top 10 Undervalued Stocks Based On Cash Flows In Europe

Name Current Price Fair Value (Est) Discount (Est) Upsales Technology (OM:UPSALE) SEK37.90 SEK75.38 49.7% Talenom Oyj (HLSE:TNOM) €3.50 €6.95 49.6% RVRC Holding (OM:RVRC) SEK45.66 SEK91.03 49.8% KebNi (OM:KEBNI B) SEK2.755 SEK5.44 49.3% Green Oleo (BIT:GRN) €0.80 €1.58 49.3% doValue (BIT:DOV) €2.488 €4.95 49.7% Digital Workforce Services Oyj (HLSE:DWF) €3.41 €6.80 49.8% BHG Group (OM:BHG) SEK25.04 SEK48.98 48.9% Atea (OB:ATEA) NOK144.00 NOK286.37 49.7% Absolent Air Care Group (OM:ABSO) SEK243.00 SEK482.96 49.7%

Click here to see the full list of 191 stocks from our Undervalued European Stocks Based On Cash Flows screener.

Below we spotlight a couple of our favorites from our exclusive screener.

Stora Enso Oyj

Overview: Stora Enso Oyj is a company that offers renewable solutions for the packaging, biomaterials, wooden constructions, and paper industries both in Finland and internationally, with a market cap of €7.54 billion.

Operations: The company's revenue segments include Packaging Materials (€4.58 billion), Forest (€3.15 billion), Wood Products (€1.67 billion), Biomaterials (€1.57 billion), and Packaging Solutions (€1.02 billion).

Estimated Discount To Fair Value: 35.5%

Stora Enso Oyj, currently trading at €9.47, is considered undervalued based on its discounted cash flow valuation of €14.68. Despite a volatile share price and a dividend not well-covered by earnings or free cash flows, the company is expected to become profitable within three years with above-market profit growth. Recent strategic reviews and organizational restructuring aim to enhance focus on renewable packaging and unlock value in its Swedish forest assets, potentially increasing shareholder value.

Upon reviewing our latest growth report, Stora Enso Oyj's projected financial performance appears quite optimistic. Navigate through the intricacies of Stora Enso Oyj with our comprehensive financial health report here.HLSE:STERV Discounted Cash Flow as at Jul 2025

Valmet Oyj

Overview: Valmet Oyj is a company that develops and supplies process technologies, automation, and services for the pulp, paper, and energy industries across various regions including North America, South America, China, Europe, the Middle East, Africa, and the Asia Pacific with a market cap of €5.76 billion.

Story Continues

Operations: Valmet Oyj's revenue is generated through its offerings in process technologies, automation, and services tailored for the pulp, paper, and energy sectors across diverse global markets.

Estimated Discount To Fair Value: 35.1%

Valmet Oyj, trading at €31.26, is undervalued against its DCF valuation of €48.19. Despite a dip in recent earnings and sales figures, the company anticipates significant annual profit growth of over 20% in the coming years. The firm’s strategic focus on sustainable technologies like biomass boilers aligns with market trends and enhances its cash flow potential, although its dividend yield of 4.32% remains unsupported by current earnings levels.

Insights from our recent growth report point to a promising forecast for Valmet Oyj's business outlook. Click here and access our complete balance sheet health report to understand the dynamics of Valmet Oyj.HLSE:VALMT Discounted Cash Flow as at Jul 2025

Galderma Group

Overview: Galderma Group AG is a global dermatology company with a market cap of CHF31.69 billion.

Operations: The company generates revenue of $4.44 billion from its dermatology segment worldwide.

Estimated Discount To Fair Value: 42.5%

Galderma Group, trading at CHF133.5, is significantly undervalued with a fair value estimate of CHF232.27 based on discounted cash flow analysis. The company's earnings are forecast to grow substantially at 31.6% annually, surpassing the Swiss market average growth rate. Recent guidance raises reflect strong sales momentum driven by new product launches in Therapeutic Dermatology and Injectable Aesthetics, although challenges remain in the Neuromodulator sector due to stocking dynamics and high comparative bases.

The growth report we've compiled suggests that Galderma Group's future prospects could be on the up. Get an in-depth perspective on Galderma Group's balance sheet by reading our health report here.SWX:GALD Discounted Cash Flow as at Jul 2025

Taking Advantage

Access the full spectrum of 191 Undervalued European Stocks Based On Cash Flows by clicking on this link. Already own these companies? Bring clarity to your investment decisions by linking up your portfolio with Simply Wall St, where you can monitor all the vital signs of your stocks effortlessly. Discover a world of investment opportunities with Simply Wall St's free app and access unparalleled stock analysis across all markets.

Looking For Alternative Opportunities?

Explore high-performing small cap companies that haven't yet garnered significant analyst attention. Diversify your portfolio with solid dividend payers offering reliable income streams to weather potential market turbulence. Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Companies discussed in this article include HLSE:STERV HLSE:VALMT and SWX:GALD.

This article was originally published by Simply Wall St.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email [email protected]